# Efficacy and Safety of Ikervis Under Controlled Environmental Conditions Environment

> **NCT04492878** · PHASE4 · COMPLETED · sponsor: **Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA** · enrollment: 25 (actual)

## Conditions studied

- Dry Eye
- Dry Eye Syndromes
- Severe Keratitis

## Interventions

- **DRUG:** IKERVIS®1mg/mL

## Key facts

- **NCT ID:** NCT04492878
- **Lead sponsor:** Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-04
- **Primary completion:** 2021-01-18
- **Final completion:** 2021-01-18
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04492878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04492878, "Efficacy and Safety of Ikervis Under Controlled Environmental Conditions Environment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04492878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*